HUMAN GENE THERAPY: At What Cost Progress?
The death of an 18-year-old man in a University of Pennsylvania gene therapy experiment has called the entire enterprise into question. Have human trials proceeded too rapidly? Are sufficient safeguards in place? California Healthline columnist Jeff Stryker looks for the therapy in gene therapy.
Stryker's Corner is a regular Monday feature in California Healthline. Columnist Jeff Stryker takes readers behind the headlines, with in- depth articles, guest editorials and interviews with California newsmakers. Click here for more on Stryker and this feature.
The views represented in this column are those of the columnist or guest editorialist and not of California Healthline or the National Journal Group.